These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. An overview of heparin-induced thrombocytopenia. Donovan JL; Tran MT; Kanaan AO J Pharm Pract; 2010 Jun; 23(3):226-34. PubMed ID: 21507818 [TBL] [Abstract][Full Text] [Related]
4. [Treatment of heparin-induced thrombocytopenia with rivaroxaban. Case report]. Rivera O G; Corsi S O; Pavlovic J A; Aizman S A; Varas A P Rev Med Chil; 2017 Sep; 145(9):1213-1217. PubMed ID: 29424412 [TBL] [Abstract][Full Text] [Related]
5. Heparin-induced thrombocytopenia: treatment options and special considerations. Dager WE; Dougherty JA; Nguyen PH; Militello MA; Smythe MA Pharmacotherapy; 2007 Apr; 27(4):564-87. PubMed ID: 17381384 [TBL] [Abstract][Full Text] [Related]
6. Design of the rivaroxaban for heparin-induced thrombocytopenia study. Linkins LA; Warkentin TE; Pai M; Shivakumar S; Manji RA; Wells PS; Crowther MA J Thromb Thrombolysis; 2014 Nov; 38(4):485-92. PubMed ID: 24549975 [TBL] [Abstract][Full Text] [Related]
7. Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome. Lewis BE; Walenga JM; Wallis DE Semin Thromb Hemost; 1997; 23(2):197-202. PubMed ID: 9200347 [TBL] [Abstract][Full Text] [Related]
10. Heparin-Induced Thrombocytopenia: A Focus on Thrombosis. Arepally GM; Padmanabhan A Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):141-152. PubMed ID: 33267665 [TBL] [Abstract][Full Text] [Related]
11. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia. Jeske WP; Walenga JM Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410 [TBL] [Abstract][Full Text] [Related]
12. Heparin-induced thrombocytopenia: an update. Prechel M; Walenga JM Semin Thromb Hemost; 2012 Jul; 38(5):483-96. PubMed ID: 22399304 [TBL] [Abstract][Full Text] [Related]
13. The laboratory diagnosis and clinical management of patients with heparin-induced thrombocytopenia: an update. Prechel M; Walenga JM Semin Thromb Hemost; 2008 Feb; 34(1):86-96. PubMed ID: 18393145 [TBL] [Abstract][Full Text] [Related]
15. Agents for the treatment of heparin-induced thrombocytopenia. Warkentin TE Hematol Oncol Clin North Am; 2010 Aug; 24(4):755-75, ix. PubMed ID: 20659659 [TBL] [Abstract][Full Text] [Related]
16. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia. Jeske WP; Walenga JM Methods Mol Med; 2004; 93():61-82. PubMed ID: 14733328 [No Abstract] [Full Text] [Related]
17. Heparin induced thrombocytopenia. Contemporary therapeutic approaches in light of the new oral anticoagulants. Sanidas EA; Viniou NA; Diamantopoulos P; Barbetseas J Hamostaseologie; 2015; 35(4):372-5. PubMed ID: 26302031 [TBL] [Abstract][Full Text] [Related]
18. Direct thrombin inhibitors for the treatment of HIT. Bamberg K JAAPA; 2012 Jun; 25(6):18. PubMed ID: 22693877 [No Abstract] [Full Text] [Related]